The nurse observes that a client with sickle cell anemia and on a blood transfusion regimen has cardiac dysrhythmias due to iron overdose toxicity. Which medication is most beneficial to this client?

The correct answer is D: Deferoxamine. Deferoxamine is a chelating agent used to treat iron toxicity. In this case, the client's cardiac dysrhythmias are due to iron overdose, and Deferoxamine helps to bind and remove excess iron from the body, thereby alleviating the toxicity and improving cardiac function. Trientine (A) is used for copper toxicity, Dimercaprol (B) for heavy metal poisoning, and Ferrous gluconate (C) is an iron supplement. These options are not appropriate for treating iron overdose toxicity in this scenario.